These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32653668)

  • 41. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision.
    Mbaba M; Brown SE; Wooditch A; Kiss M; Murphy A; Kumari S; Taxman F; Altice F; Lawson WB; Springer SA
    Subst Use Misuse; 2018 Jul; 53(9):1519-1528. PubMed ID: 29333954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.
    Soares WE; Wilson D; Gordon MS; Lee JD; Nunes EV; O'Brien CP; Shroff M; Friedmann PD
    Drug Alcohol Depend; 2019 Jan; 194():482-486. PubMed ID: 30522048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barriers and facilitators to implementing an urban co-responding police-mental health team.
    Bailey K; Paquet SR; Ray BR; Grommon E; Lowder EM; Sightes E
    Health Justice; 2018 Nov; 6(1):21. PubMed ID: 30467739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linking Opioid-Overdose Data to Human Services and Criminal Justice Data: Opportunities for Intervention.
    Hacker K; Jones LD; Brink L; Wilson A; Cherna M; Dalton E; Hulsey EG
    Public Health Rep; 2018 Nov; 133(6):658-666. PubMed ID: 30300555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual.
    Soares WE; Wilson D; Rathlev N; Lee JD; Gordon M; Nunes EV; O'Brien CP; Friedmann PD
    J Subst Abuse Treat; 2018 Feb; 85():66-69. PubMed ID: 28576389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic burden of opioid crisis and the role of pharmacist-led interventions.
    Sanyal C
    J Am Pharm Assoc (2003); 2021; 61(3):e70-e74. PubMed ID: 33279425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coverage of the opioid crisis in national network television news from 2000-2020: A content analysis.
    Jay J; Chan A; Gayed G; Patterson J
    Subst Abus; 2022; 43(1):1322-1332. PubMed ID: 35896005
    [No Abstract]   [Full Text] [Related]  

  • 50. Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
    Andraka-Christou B; Gabriel M; Madeira J; Silverman RD
    J Subst Abuse Treat; 2019 Sep; 104():72-82. PubMed ID: 31370988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breaking the cycle: A public-private partnership to combat the American opioid epidemic.
    Soled D; Uppal N; Weiner SG
    Healthc (Amst); 2021 Dec; 9(4):100592. PubMed ID: 34739979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid misuse viewed through person and place in the rural West.
    Voss MW; Yaugher AC; Atismé K; Campbell A
    J Opioid Manag; 2022; 18(2):151-159. PubMed ID: 35476884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations in the California Emergency Medical Services Response to Opioid Use Disorder.
    Glober NK; Hern G; McBride O; Mercer MP
    West J Emerg Med; 2020 Apr; 21(3):671-676. PubMed ID: 32421518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Opioid Crisis and the Future of Addiction and Pain Therapeutics.
    Coussens NP; Sittampalam GS; Jonson SG; Hall MD; Gorby HE; Tamiz AP; McManus OB; Felder CC; Rasmussen K
    J Pharmacol Exp Ther; 2019 Nov; 371(2):396-408. PubMed ID: 31481516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cohort profile: seek, test, treat and retain United States criminal justice cohort.
    Chandler R; Gordon MS; Kruszka B; Strand LN; Altice FL; Beckwith CG; Biggs ML; Cunningham W; Chris Delaney JA; Flynn PM; Golin CE; Knight K; Kral AH; Kuo I; Lorvick J; Nance RM; Ouellet LJ; Rich JD; Sacks S; Seal D; Spaulding A; Springer SA; Taxman F; Wohl D; Young JD; Young R; Crane HM
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):24. PubMed ID: 28511680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy.
    Csete J
    Am J Public Health; 2019 Mar; 109(3):419-422. PubMed ID: 30676805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.
    Andraka-Christou B
    Health Aff (Millwood); 2021 Jun; 40(6):920-927. PubMed ID: 34097509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response.
    Morrow JB; Ropero-Miller JD; Catlin ML; Winokur AD; Cadwallader AB; Staymates JL; Williams SR; McGrath JG; Logan BK; McCormick MM; Nolte KB; Gilson TP; Menendez MJ; Goldberger BA
    J Anal Toxicol; 2019 Jan; 43(1):1-9. PubMed ID: 30165647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.